Patient profile impacts QOL with radiation Tx in head, neck cancer

August 11, 2017

(HealthDay)—There are patient characteristics and clinical factors independently associated with physical and mental quality of life (QOL) in patients with head and neck cancer undergoing radiotherapy, according to a study published online Aug. 2 in Head & Neck.

Guro Lindviksmoen Astrup, from Oslo University Hospital in Norway, and colleagues evaluated 133 patients with head and . From the initiation of radiotherapy through six months of follow-up, patients rated physical and mental QOL using the Short Form-12 five times.

The researchers found that QOL deteriorated during radiotherapy and gradually improved after completion. There was a negative association between less and both physical and mental QOL. There were also negative associations between older age, more comorbidities, more psychological symptoms, and concomitant chemotherapy with physical QOL. There were positive associations for male sex, fewer physical symptoms, surgery before , and concomitant chemotherapy with mental QOL.

"Clinicians can use knowledge on time course and associated characteristics to identify and inform patients at higher risk for diminished QOL," the authors write.

Explore further: More side effects with CRT plus metformin in head, neck cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

More side effects with CRT plus metformin in head, neck cancer

May 7, 2017
(HealthDay)—Patients with advanced head and neck cancer undergoing chemoradiotherapy (CRT) and receiving metformin experience more side effects than patients not on metformin, according to research published online April ...

Depression up in post-radiation head and neck cancer survivors

August 16, 2013
(HealthDay)—For post-radiotherapy survivors of head and neck cancer, depression is fairly common, but treatment is underutilized, according to research published online Aug. 15 in JAMA Otolaryngology-Head & Neck Surgery.

Reduced cancer-independent life expectancy in head, neck cancer

June 27, 2017
(HealthDay)—Patients with head and neck cancer have reduced life expectancy, independent of cancer, according to a study published online June 22 in Head & Neck.

Empowerment linked to HRQoL in teen, young adult CA survivors

July 17, 2017
(HealthDay)—For adolescent and young adult (AYA) cancer survivors, empowerment is independently associated with health-related quality of life (HRQoL), according to research published online July 11 in Cancer.

Researchers urge radiotherapy for all patients with bone mets

February 13, 2017
(HealthDay)—For patients with bone metastases, those responding to radiotherapy experience greater pain reduction and better quality of life (QOL) at day 10 after radiotherapy, according to a study published online Feb. ...

High-observation protocol cuts length of stay in head, neck CA

July 7, 2017
(HealthDay)—A high-observation protocol (HOP) appears to optimize clinical care for patients with head and neck cancer undergoing primary surgery, according to a study published online June 20 in Head & Neck.

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.